Sonoma Pharmaceuticals, Inc. cotiza a 1.23 USD y tiene una capitalización bursátil de $6M. En los últimos 12 meses ha facturado $22M con un margen de flujo de caja libre del -21.1%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a p…
| Periodo | 2026-02 | 2025-11 | 2025-08 | 2025-02 |
|---|---|---|---|---|
| Real | $-0.48 | $-0.32 | $-0.76 | $-0.63 |
| Estimado | $-0.29 | $-0.31 | $-0.51 | $-0.60 |
| Sorpresa | -65.5% | -3.2% | -49.0% | -5.0% |
| Métrica | SNOA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 38.0% | 57.0% | -19.1% |
| Operating Margin | -12.6% | -38.6% | +26.0% |
| Net Margin | -16.3% | -33.6% | +17.3% |
| FCF Margin | -21.1% | -13.9% | -7.3% |
| ROE | -102.6% | -40.4% | -62.2% |
| ROA | -22.7% | -32.0% | +9.3% |
| Current Ratio | 2.50 | 2.84 | -0.34 |
| Debt / Equity | — | 0.28 | — |